Stable HEV IgG seroprevalence in Belgium between 2006 and 2014.
Belgium
Europe
epidemiology
hepatitis E
Journal
Journal of viral hepatitis
ISSN: 1365-2893
Titre abrégé: J Viral Hepat
Pays: England
ID NLM: 9435672
Informations de publication
Date de publication:
11 2020
11 2020
Historique:
received:
20
01
2020
revised:
15
04
2020
accepted:
05
06
2020
pubmed:
22
6
2020
medline:
26
8
2021
entrez:
22
6
2020
Statut:
ppublish
Résumé
Recent European studies suggest an emergence of hepatitis E virus (HEV) infection. We evaluated trends in birth cohort-specific HEV seroprevalence and regional differences in Belgium. HEV IgG seroprevalence was analysed on national serum banks (1579 and 2087 samples for 2006 and 2014, respectively. Hepatitis E virus antigen was tested on positive samples. Observed data were modelled using a generalized additive model with a complementary log-log link. No significant differences between birth cohorts or sexes were found. Modelling identified the individual's age and province as relevant factors. The probability of HEV seropositivity increases significantly with age. An estimated total of 434 819 (yearly rate of 54,352) (sero-)infections were found between 2006 and 2014. Overall, HEV IgG seroprevalences were 4.1% (64/1579, 95% CI 3.1-5.1) and 5.8% (121/2087, CI 4.8-6.9) in 2006 and 2014, respectively. Observed HEV antigen seroprevalence was 0.027% (1/3666) for the entire cohort. These results show stable HEV IgG seroprevalence in Belgium.
Substances chimiques
Hepatitis Antibodies
0
Immunoglobulin G
0
Immunoglobulin M
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1253-1260Informations de copyright
© 2020 John Wiley & Sons Ltd.
Références
Kamar N, Selves J, Mansuy JM, et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med. 2008;358(8):811-817.
van Eijk JJJ, Dalton HR, Ripellino P, et al. Clinical phenotype and outcome of hepatitis E virus-associated neuralgic amyotrophy. Neurology. 2017;89(9):909-917.
Hogema BM, Molier M, Slot E, Zaaijer HL. Past and present of hepatitis E in the Netherlands. Transfusion. 2014;54(12):3092-3096.
Ijaz S, Vyse AJ, Morgan D, Pebody RG, Tedder RS, Brown D. Indigenous hepatitis E virus infection in England: more common than it seems. J Clin Virol. 2009;44(4):272-276.
Mansuy JM, Gallian P, Dimeglio C, et al. A nationwide survey of hepatitis E viral infection in French blood donors. Hepatology. 2016;63(4):1145-1154.
Kamar N, Bendall R, Legrand-Abravanel F, et al. Hepatitis E. Lancet. 2012;379(9835):2477-2488.
Hartl J, Otto B, Madden RG, et al. Hepatitis E Seroprevalence in Europe: a meta-analysis. Viruses. 2016;8(8):211.
Pas SD, Streefkerk RH, Pronk M, et al. Diagnostic performance of selected commercial HEV IgM and IgG ELISAs for immunocompromised and immunocompetent patients. J Clin Virol. 2013;58(4):629-634.
European Centre for Disease Prevention and Control. Hepatitis E in the EU/EEA, 2005-2015. Stockholm, Sweden: ECDC; 2017.
Aspinall EJ, Couturier E, Faber M, et al. Hepatitis E virus infection in Europe: surveillance and descriptive epidemiology of confirmed cases, 2005 to 2015. Euro Surveill. 2017;22(26):30561.
Golding J, Northstone K, Miller LL, Davey Smith G, Pembrey M. Differences between blood donors and a population sample: implications for case-control studies. Int J Epidemiol. 2013;42(4):1145-1156.
Hofstraat SHI, Falla AM, Duffell EF, et al. Current prevalence of chronic hepatitis B and C virus infection in the general population, blood donors and pregnant women in the EU/EEA: a systematic review. Epidemiol Infect. 2017;145(14):2873-2885.
Janssen MP, Collection RG. Testing and Use of Blood and Blood Components in Europe - 2015 report. 2015. Strasbourg, France: European Directorate for the Quality of Medicines.
Morrison A, Stone DH. Injury surveillance in accident and emergency departments: to sample or not to sample? Inj Prev. 1998;4(1):50-52.
van Hoeven LR, Janssen MP, Roes KC, Koffijberg H. Aiming for a representative sample: Simulating random versus purposive strategies for hospital selection. BMC Med Res Methodol. 2015;15:90.
Kelly H, Riddell MA, Gidding HF, Nolan T, Gilbert GL. A random cluster survey and a convenience sample give comparable estimates of immunity to vaccine preventable diseases in children of school age in Victoria, Australia. Vaccine. 2002;20(25-26):3130-3136.
Theeten H, Hutse V, Hens N, et al. Are we hitting immunity targets? The 2006 age-specific seroprevalence of measles, mumps, rubella, diphtheria and tetanus in Belgium. Epidemiol Infect. 2011;139(4):494-504.
Champely S. (2018). pwr: basic functions for power analysis. R package version 1.2-2. https://CRAN.R-project.org/package=pwr
Core R, Team R. A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2017.
Wood SN. Generalized Additive Models: An Introduction with R. Boca Raton, FL: CRC Press; 2006.
Akaike H. Information theory and an extension of the maximum likelihood principle. In: Petrov BN, Csaki F, eds. Proceeding of the Second International Symposium on Information Theory. Budapest, Hungary: Academiai Kiado; 1973:267-281.
Hens N, Shkedy Z, Aerts M, Faes C, Damme P, Beutels P. Modelling infectious disease parameters based on serological and social contact data: a modern statistical perspective. 2013. https://doi.org/10.1007/978-1-4614-4072-7
Statbel (Algemene Directie Statistiek - Statistics Belgium) FOD Economie, K.M.O., Middenstand en Energie - retrieved from https://bestat.statbel.fgov.be/bestat/crosstable.xhtml?view=1b9e219b-0387-4a70-880a-dc5eccaa244c - 6-10-2019
Olsøy IB, Henriksen S, Weissbach FH, et al. Seroprevalence of hepatitis E virus (HEV) in a general adult population in Northern Norway: the Tromsø study. Med Microbiol Immunol. 2019;208(6):715-725.
Faber M, Willrich N, Schemmerer M, et al. Hepatitis E virus seroprevalence, seroincidence and seroreversion in the German adult population. J Viral Hepat. 2018;25(6):752-758.
Suin V, Klamer SE, Hutse V, et al. Epidemiology and genotype 3 subtype dynamics of hepatitis E virus in Belgium, 2010 to 2017. Euro Surveill. 2019; 24(10):1800141. https://doi.org/10.2807/1560-7917.ES.2019.24.10.1800141
Alfonsi V, Romanò L, Ciccaglione AR, et al. Hepatitis E in Italy: 5 years of national epidemiological, virological and environmental surveillance, 2012 to 2016. Euro Surveill. 2018; 23(41):1700517. https://doi.org/10.2807/1560-7917.ES.2018.23.41.1700517
Al-Sadeq DW, Majdalawieh AF, Mesleh AG, Abdalla OM, Nasrallah GK. Laboratory challenges in the diagnosis of hepatitis E virus. J Med Microbiol. 2018;67(4):466-480.